2021
DOI: 10.3390/children8020126
|View full text |Cite
|
Sign up to set email alerts
|

Relapse of Neonatal Escherichia coli Meningitis: Did We Miss Something at First?

Abstract: Relapse of neonatal meningitis is most commonly caused by Escherichia coli. Management to prevent relapse varies and evidence is limited. We present four cases of relapsing neonatal E. coli meningitis in Denmark in 2016–2017 and review the current literature on this subject. During the primary episodes, our patients received cephalosporin for 3 weeks and gentamicin for the first 3 days. The only identified risk factor was delayed CSF sterilization in three of four cases and no repeated lumbar puncture. Relapse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 11 publications
1
14
0
Order By: Relevance
“…Therefore, the CSF samples in the remission stage were further divided into non-refractory and refractory remission, in which the corresponding disease durations were less than or greater than 28 days, respectively, during which time BM patients experienced satisfactory or unsatisfactory therapeutic effects, respectively. A recent study (45) showed that BM patients with unsatisfactory therapeutic effects presented with abnormally increased CSF TCC; in our study, some CSF of BM patients with disease durations less than 28 days showed clearly relapsed TCC values, such as C25, C40, and C97, and were classified into the "refractory remission" group. Similarly, CSF samples from BM patients in the recovery stage were divided into "recovery after non-refractory remission" or "recovery after refractory remission" groups, in which the latter group also included patients with a disease duration less than 28 days but who had recovered from a refractory condition (Figure 2A).…”
Section: Classifying Csf Samples and Their Represented Bm Onset Condi...supporting
confidence: 52%
“…Therefore, the CSF samples in the remission stage were further divided into non-refractory and refractory remission, in which the corresponding disease durations were less than or greater than 28 days, respectively, during which time BM patients experienced satisfactory or unsatisfactory therapeutic effects, respectively. A recent study (45) showed that BM patients with unsatisfactory therapeutic effects presented with abnormally increased CSF TCC; in our study, some CSF of BM patients with disease durations less than 28 days showed clearly relapsed TCC values, such as C25, C40, and C97, and were classified into the "refractory remission" group. Similarly, CSF samples from BM patients in the recovery stage were divided into "recovery after non-refractory remission" or "recovery after refractory remission" groups, in which the latter group also included patients with a disease duration less than 28 days but who had recovered from a refractory condition (Figure 2A).…”
Section: Classifying Csf Samples and Their Represented Bm Onset Condi...supporting
confidence: 52%
“…coli is a representative bacterium of the genus Escherichia. Intestinal and extraintestinal infections, including urinary tract infections, arthritis, meningitis, and septicaemia, can be caused under certain conditions. To verify this, we constructed an E. coli-induced myositis murine model.…”
Section: Resultsmentioning
confidence: 99%
“…The ExPEC pathotype is divided into six main sub-pathotypes [50,58], including uropathogenic E. coli (UPEC) [88][89][90][91][92], sepsis/newborn meningitis-associated E. coli (NMEC) [93][94][95][96], APEC [45,[97][98][99][100][101][102], sepsis-associated pathogenic E. coli (SePEC) [103,104], mammary pathogenic E. coli [105][106][107][108], and endometrial pathogenic E. coli [109,110]. The ExPEC strain was characterized as E. coli isolate containing two or more virulence factors.…”
Section: Avian Pathogenic E Colimentioning
confidence: 99%